RCT of the Naturopathic Anti-Inflammatory Diet

NCT ID: NCT00334919

Last Updated: 2010-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-05-31

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if the naturopathic Anti-Inflammatory Diet results in reduced inflammation and a better response by the immune system when compared to a standard diabetic diet based on the current American Diabetes Association guidelines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will test the effects of two different diets on the immune system and inflammation in diabetes and pre-diabetes. These diets are the "Anti-Inflammatory Diet" (AI Diet) used by many naturopathic doctors and a standard diabetic diet based on the American Diabetes Association recommendations (ADA Diet). The AI diet excludes wheat, dairy products, eggs, red meat, caffeine, alcohol, peanuts and certain fruits and vegetables. The ADA diet includes most foods but controls the amount of each of the food groups.

Naturopathic physicians often use healthful diets to treat diseases but many of these diets have not been compared to usual medical diet treatments. We will be looking at blood markers that show how the immune system responds to the different diets. We are expecting that the AI diet will result in less inflammation and a better response by the immune system than the ADA diet. We will also be looking at levels of blood lipids and glucose to see any effects on these risk factors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2 Prediabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diet (Anti-Inflammatory or standard diabetic diet)

6 weeks standard ADA diet, then randomized to either ADA or antiinflammatory (AI) diet for 6 weeks

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI: 25-45 kg/m2
* Age 18-75 yrs
* Diagnosed with type 2 diabetes or pre-diabetes
* At risk for type 2 diabetes. Must meet 2 of the following 3 criteria: BMI 30-45 kg/m2, age 50 or older, and/or family history of type 2 diabetes
* Fasting blood glucose of 100-200 mg/dl
* Provide informed consent

Exclusion Criteria

* Current major debilitating mental or physical illness that would interfere with participation (as determined by the participant's medical history)
* Taking diabetic medication other than sulfonylurea
* Taking Gymnema silvestra (a naturopathic diabetes treatment)
* Taking medications that have anti-inflammatory affects (lipid lowering agents, NSAIDS, COX 2 inhibitors, aspirin, HRT, oral contraceptives, testosterone, seizure medications)
* Taking weight loss medications
* Severe renal, hepatic, or heart disease
* Triglycerides \>500 mg/dL
* Bulimia
* Pregnancy or lactation
* Current excessive use of alcohol
* Current/recent chronic use of recreational drugs
* Smoker
* More than 4 hours/week of aerobic exercise
* Have gained or lost more than 15 pounds during previous 6 months
* Planning on moving out of the area in the next 4 months
* Is a participant in another medical research study
* Is following a weight loss diet
* Is unwilling to accept random assignment of the experimental diets
* Food preferences and/or allergies that will interfere with consumption of experimental diet
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center for Complementary and Integrative Health (NCCIH)

NIH

Sponsor Role collaborator

National University of Natural Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Helfgott Research Institute

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patricia Elmer, PhD

Role: PRINCIPAL_INVESTIGATOR

National College of Naturopathic Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oregon Health & Science University General Clinical Research Center

Portland, Oregon, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R21AT002374-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R21AT002374-01A1

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Integrative Care for Type 2 Diabetes
NCT02843724 UNKNOWN PHASE1/PHASE2
Zinc Supplementation in Type 2 Diabetics
NCT01309620 COMPLETED PHASE2/PHASE3
Effects of Selenium Towards Type 2 Diabetes
NCT06457984 NOT_YET_RECRUITING NA